October 21, 2025
Anti-tumor Vaccine Efficacy Related to Glycan Profile
On October 6, 2025, Marc Ehlers et al. from the University of Lübeck in Germany published an article titled "Anti-tumor vaccine efficacy depends on adjuvant type and associates with induced IgG subclass and glycosylation profiles" in Experimental Hematology & Oncology. This study systematically compared the protective effects of various Vaccine Adjuvants in tumor models and found […]
Read More >